Seizure Control Articles & Analysis: Older
8 news found
The jointly developed therapy features a micro-infusion device that tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. ADDRESS is the first multi-center dose ranging clinical study assessing intracerebroventricular (ICV) delivery of the drug valproate (valproate sodium) in patients with focal seizures, with ...
It is widely recognized that alternatives to antiepileptic drugs (AEDs) and surgery are a significant unmet medical need, especially for patients with incomplete seizure control who may not be candidates for, or wish to avoid the risks of, surgery and implantable devices. ...
In comparison to standard CBD, CQ-001 (cannabidiol "CBD" + IP formula - essential fatty acids) demonstrated 40% more seizure reduction at a medium dose in the maximal electroshock seizure (MES) model. This result indicates that CQ-001 is stronger than standard CBD, and could be used a lower dose to achieve seizure control. ...
The core of the product is the AI algorithm to detect absence seizures, and upon detection, seizures are automatically signalled and logged and they can be automatically video-recorded too. Different from convulsive seizures, absence seizures are difficult-to-notice, short and the person is not aware of having them. ...
Using the SPEAC-recorded physiologic sEMG and audio data, physicians may quantify and qualify the types of seizure events their patients experience. Approximately one-third of people living with seizures report their anti-seizure medication (ASM) is not adequately controlling their episodes. ...
Approximately one-third of people with epilepsy do not have control over their seizures and another third can only partially control their seizures (Baker, 1997). Studies have shown that about 50% of seizures happen at night (Herman, 2001) and 86% of nocturnal seizures are not documented (Hoppe, ...
Approximately one-third of people with epilepsy do not have control over their seizures and another third can only partially control their seizures (Baker, 1997). Studies have shown that about 50% of seizures happen at night (Herman, 2001) and 86% of nocturnal seizures are not documented (Hoppe, ...
The SPEAC® System is the first and only FDA-cleared, non-EEG, physiological signal-based system for seizure monitoring. “Validation of sEMG as a useful biomarker in the monitoring of our seizure patients gives us a new tool to help patients get their seizures under control,” said Jonathan Halford, M.D., lead ...